[1-(5-fluoropyridin-2-yl)cyclopropyl]methanamine dihydrochloride, 1g

TRANS-STILBENE, 95%, 5g

7-ethynyl-2H-indazole, 97%, 5g

Ethyl 2-cyclohexylacetate, 95.0%, 1g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 100mL, >=99%, for peptide synthesis

tert-Butyl 4-(2-amino-4-fluorophenylamino)piperidine-1-carboxylate, 95.0%, 1g

Nicotinic Acid Hydrazide>98.0%(T)100g

Methyl 4-bromo-2-chloro-6-methylbenzoate, 95.0%, 1g

(2-Ethynylphenyl)methanamine hydrochloride, 95.0%, 1g

TRANS-METHYL 1-BENZYL-4-(BOC-AMINO)PIPERIDINE-3-CARBOXYLATE, 95.0%, 1g

1,3-Bis[3,5-bis(trifluoromethyl)phenyl]thiourea>98.0%(N)200mg

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-D-homocysteine, 95+%, 5g

(5-Bromopyridin-3-yl)(pyrrolidin-1-yl)methanone, 95.0%, 1g